GLOSSARY

Research terms glossary

50 terms · Updated 2026-05-18

Share this

EmailXText

Clear, methodological definitions of terms frequently encountered in anxiety research, clinical trials, and epidemiological data.

Study design

  • Randomized controlled trialA randomized controlled trial, often shortened to RCT, is a study that tests whether a treatment works by splitting people into groups at random. One group gets the treatment. Another group gets a comparison, such as a placebo or usual care.
  • Systematic reviewA systematic review is a careful, organized summary of all the studies that have looked at the same question. It follows a written plan, so the process can be checked and repeated by someone else.
  • Meta-analysisA meta-analysis is a math method that combines the results of several studies into one overall number. It often sits inside a systematic review.
  • Network meta-analysisA network meta-analysis compares several treatments at once, including some that were never tested directly against each other in the same study.
  • Cohort studyA cohort study follows a group of people over time to see what happens to them. It watches; it doesn't assign treatment.
  • Cross-sectional studyA cross-sectional study takes a snapshot of a population at one moment in time. It measures things once, not over a stretch of time.
  • Case-control studyA case-control study starts with the outcome. It compares people who already have a condition, the cases, with similar people who don't, the controls, then looks back to find differences.
  • Intention-to-treat analysisIntention-to-treat means a trial counts every person in the group they were first assigned to, even if they stopped the treatment or dropped out partway through.
  • Pragmatic trialA pragmatic trial tests a treatment in everyday conditions, with the kind of patients and clinics you'd see in normal care.
  • BlindingBlinding means hiding who got which treatment, so that knowledge doesn't skew the results.
  • Control groupThe control group is the comparison group in a study. It doesn't get the treatment being tested, so researchers have something to measure the treatment against.
  • PlaceboA placebo is an inactive treatment, such as a sugar pill, used for comparison. It contains no active drug.

Statistics

  • PrevalencePrevalence is the share of a population that has a condition at a given time. It answers the question "how many people have this."
  • IncidenceIncidence is the rate at which new cases of a condition appear in a population over a period of time. It counts only the new cases.
  • Odds ratioAn odds ratio compares the odds of an outcome in one group with the odds in another. It's a way to measure how strongly two things are linked.
  • Relative riskRelative risk compares the chance of an outcome in one group with the chance in another. A relative risk of 1 means no difference.
  • Hazard ratioA hazard ratio compares how quickly an outcome happens in one group versus another over time. It's about timing, not only whether something happens.
  • Confidence intervalA confidence interval is a range of values that probably contains the true answer. It shows how precise a study's result is.
  • p-valueA p-value is a number that tells you how surprising a result would be if the treatment actually did nothing. A small p-value means the result would be unlikely by chance alone.
  • Statistical significanceA result is statistically significant when it's unlikely to be explained by chance alone. It is usually decided by a p-value below a set cutoff, often 0.05.
  • Clinical significanceClinical significance asks whether a result is big enough to make a real difference to a patient's life. It is different from statistical significance.
  • Effect sizeAn effect size is a number that describes how large a treatment's effect is. It lets you compare results across different studies and different measures.
  • Number needed to treat (NNT)The number needed to treat, or NNT, is how many people would need to receive a treatment for one extra person to benefit.
  • Number needed to harm (NNH)The number needed to harm, or NNH, is how many people would need to receive a treatment for one extra person to experience a particular harm, such as a side effect.
  • HeterogeneityHeterogeneity is the amount that study results differ from each other when they're combined in a meta-analysis. High heterogeneity means the studies disagreed.
  • Minimal clinically important differenceThe minimal clinically important difference, or MCID, is the smallest change on a symptom scale that a patient would actually notice and consider meaningful.
  • Dose-responseA dose-response relationship means that more of something is linked to more of an effect. As the dose goes up, the response changes in step.

Clinical outcomes

  • ComorbidityComorbidity means having two or more health conditions at the same time.
  • RemissionRemission means a condition's symptoms have dropped low enough that the person no longer meets the criteria for the diagnosis. The condition is quiet, though not necessarily gone for good.
  • Response rateThe response rate is the share of people in a study who improved by a set amount, often a 50 percent drop in symptoms.
  • RelapseRelapse is the return of a condition's symptoms after a period of improvement or remission.
  • Treatment adherenceTreatment adherence is how closely a person follows a treatment as it was planned, such as taking a medication regularly or attending therapy sessions.
  • DropoutDropout is when a participant leaves a study before it ends, or a patient stops a treatment before completing it.
  • Discontinuation syndromeDiscontinuation syndrome is a set of symptoms that can appear when a person stops or quickly lowers an antidepressant, such as an SSRI or SNRI.
  • Sustained responseA sustained response means an improvement that holds up over time, rather than fading after a few weeks.
  • Patient-reported outcomeA patient-reported outcome is a result measured by what the patient says about their own health, rather than by a lab test or a clinician's rating.

Treatment research

  • Generalized anxiety disorderA chronic condition characterized by excessive, uncontrollable worry about everyday issues.
  • Social anxiety disorderAn intense, persistent fear of being watched and judged by others in social situations.
  • Cognitive behavioral therapyCognitive behavioral therapy, or CBT, is a structured, time-limited talk therapy. It works on the links between thoughts, feelings, and behavior.
  • Exposure therapyA behavioral treatment in which patients repeatedly and systematically engage with feared stimuli, situations, or sensations to weaken fear responses.
  • Interoceptive exposureInteroceptive exposure is a CBT technique that has a person bring on the body sensations they fear, on purpose and in a safe setting, so those sensations feel less threatening over time.
  • SSRIAn SSRI, or selective serotonin reuptake inhibitor, is a class of antidepressant medication. SSRIs are also a first-line medication for most adult anxiety disorders.
  • SNRIAn SNRI, or serotonin-norepinephrine reuptake inhibitor, is a class of antidepressant medication. SNRIs are also used as a first-line medication for several anxiety disorders.
  • BenzodiazepineA benzodiazepine is a class of medication that calms the nervous system quickly. Benzodiazepines reduce acute anxiety fast, but long-term use carries real risks.

Conditions

  • Panic disorderPanic disorder is an anxiety disorder marked by repeated, unexpected panic attacks and ongoing worry about having more of them.

Tools and instruments

  • Screening toolA screening tool is a short, standardized questionnaire that flags whether a person may have a condition and should be assessed further. It doesn't make a diagnosis.
  • GAD-7The GAD-7 is a short, seven-question form used to screen for and measure generalized anxiety. The letters stand for Generalized Anxiety Disorder 7-item scale.
  • PHQ-9The PHQ-9 is a short, nine-question form used to screen for and measure depression. The letters stand for Patient Health Questionnaire 9-item scale.
  • DSM-5-TRThe DSM-5-TR is the handbook US clinicians use to name and define mental health conditions. The letters stand for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision.
  • ICD-11The ICD-11 is the global system for classifying diseases and health conditions, including mental health conditions. ICD stands for International Classification of Diseases, and 11 is the current edition.

Public health terms

    Share this

    EmailXText